PDS Biotechnology to Present at B. Riley Securities Virtual Oncology Conference

NEXT STORY
Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
PREV STORY
Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials™ and Accelerate Study Timelines
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Clinical Trials Market Analysis Report 2021: Phase III Clinical Trials Dominated the Market with a Share of 53.2% in 2020 – Forecast to 2028

author_avatar
NASDAQ Market News

Oncobiologics Issues $8.35 Million of Senior Secured Notes and Warrants to Acquire 1.9 Million Shares as part of Aggregate $10.0 Million Note and 2.3 Million Warrant Offering

CRANBURY, N.J., Dec. 23, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results

author_avatar
NASDAQ Market News